Company Filing History:
Years Active: 2012
Title: Mohammed Daghisch: Innovator in Serine Protease Inhibitors
Introduction
Mohammed Daghisch is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. His work focuses on creating innovative solutions for medical applications, especially in the context of blood loss treatment.
Latest Patents
Daghisch holds a patent for "Trypsin-like serine protease inhibitors, and their preparation and use." This invention relates to inhibitors of trypsin-like serine proteases, which also inhibit plasma kallikrein. The patent outlines their preparation and use as medicaments, particularly for treating blood loss in hyperfibrinolytic states, organ transplants, and heart surgery interventions, especially during cardiopulmonary bypass procedures.
Career Highlights
Daghisch is associated with The Medicines Company (Leipzig) GmbH, where he continues to advance his research and development efforts. His work has the potential to significantly impact medical practices related to surgical procedures and trauma care.
Collaborations
Some of his notable coworkers include Torsten Steinmetzer and Andrea Schweinitz. Their collaborative efforts contribute to the innovative research environment at The Medicines Company.
Conclusion
Mohammed Daghisch is a prominent figure in the field of biochemistry, with a focus on serine protease inhibitors. His patent work and collaborations highlight his commitment to advancing medical treatments.